What is the share price of Rainbow Children's Medicare Ltd (RAINBOW) today?
The share price of RAINBOW as on 18th March 2026 is ₹1123.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Rainbow Children's Medicare Ltd (RAINBOW) share?
The past returns of Rainbow Children's Medicare Ltd (RAINBOW) share are- Past 1 week: -4.43%
- Past 1 month: -7.86%
- Past 3 months: -15.12%
- Past 6 months: -22.43%
- Past 1 year: -13.47%
- Past 3 years: 51.88%
- Past 5 years: 149.64%
What are the peers or stocks similar to Rainbow Children's Medicare Ltd (RAINBOW)?
The peers or stocks similar to Rainbow Children's Medicare Ltd (RAINBOW) include:What is the dividend yield % of Rainbow Children's Medicare Ltd (RAINBOW) share?
The current dividend yield of Rainbow Children's Medicare Ltd (RAINBOW) is 0.27.What is the market cap of Rainbow Children's Medicare Ltd (RAINBOW) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Rainbow Children's Medicare Ltd (RAINBOW) is ₹11446.40 Cr as of 18th March 2026.What is the 52 week high and low of Rainbow Children's Medicare Ltd (RAINBOW) share?
The 52-week high of Rainbow Children's Medicare Ltd (RAINBOW) is ₹1645.70 and the 52-week low is ₹1090.What is the PE and PB ratio of Rainbow Children's Medicare Ltd (RAINBOW) stock?
The P/E (price-to-earnings) ratio of Rainbow Children's Medicare Ltd (RAINBOW) is 47.02. The P/B (price-to-book) ratio is 7.76.Which sector does Rainbow Children's Medicare Ltd (RAINBOW) belong to?
Rainbow Children's Medicare Ltd (RAINBOW) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Rainbow Children's Medicare Ltd (RAINBOW) shares?
You can directly buy Rainbow Children's Medicare Ltd (RAINBOW) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Rainbow Children's Medicare Ltd
RAINBOW Share Price
NSE₹1,123.900.32% (-3.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
RAINBOW Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
RAINBOW Performance & Key Metrics
RAINBOW Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 44.43 | 7.76 | 0.27% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.79 | 5.65 | 0.60% |
100%
Analysts have suggested that investors can buy this stock
from 10 analysts
Price Upside
Earnings Growth
Rev. Growth
RAINBOW Company Profile
Rainbow Children’s Medicare is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric, and obstetrics and gynecology hospitals.
APOLLOHOSP
PE Ratio
74.58
74.58
1Y Return
19.60%
19.60%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
88.32
88.32
1Y Return
3.65%
3.65%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
79.98
79.98
1Y Return
37.53%
37.53%
Buy Reco %
82.35
82.35
ASTERDM
PE Ratio
6.44
6.44
1Y Return
54.15%
54.15%
Buy Reco %
100.00
100.00
PE Ratio
42.59
42.59
1Y Return
4.51%
4.51%
Buy Reco %
80.00
80.00
RAINBOW Sentiment Analysis
RAINBOW Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
RAINBOW Stock Summary · February 2026
The company is experiencing robust growth, highlighted by a 12% year-over-year revenue increase and a stable payor mix, while also facing challenges related to occupancy rates and seasonal fluctuations in pediatric care. Despite operational hurdles, including project delays and increased competition from multi-specialty hospitals, management is committed to enhancing service levels and optimizing existing resources. Strategic investments in digital transformation aim to improve patient engagement and streamline operations, positioning the organization to capture a larger market share. As it expands its pediatric liver transplant program and strengthens its clinical capabilities, the company remains focused on achieving long-term EBITDA margins of 24% to 25%, ensuring sustainable growth amidst evolving market dynamics.
RAINBOW Stock Growth Drivers
RAINBOW Stock Growth Drivers
8Operational Performance Improvements
Rainbow Children's Medicare Limited has reported steady improvements across key operational metrics, including outpatients, footfalls,
Financial Growth
For Q3 FY '26, the company reported a revenue of INR 445.4 crores, reflecting a
RAINBOW Stock Challenges
RAINBOW Stock Challenges
6Decline in Patient Volumes and Revenue
The company has experienced a decline in outpatient and inpatient volumes, leading to flat revenues
Projected EBITDA Losses for New Units
The company anticipates full-year EBITDA losses for its new hospital units in Bangalore, specifically the
RAINBOW Forecast
RAINBOW Forecasts
Price
Revenue
Earnings
RAINBOW Share Price Forecast
RAINBOW Share Price Forecast
2026
Current
₹1,123.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹1,123.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
RAINBOW Company Revenue Forecast
RAINBOW Company Revenue Forecast
2025
Current
₹1.57
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.57
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
RAINBOW Stock EPS (Earnings Per Share) Forecast
RAINBOW Stock EPS (Earnings Per Share) Forecast
2025
Current
₹23.98
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹23.98
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
RAINBOW
RAINBOW
Income
Balance Sheet
Cash Flow
Quarterly Normal View
RAINBOW Income Statement
RAINBOW Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 340.50 | 344.57 | 353.88 | 342.15 | 428.73 | 411.36 | 384.63 | 372.95 | 452.99 | 455.96 | ||||||||||
Operating & Other expenses | 215.11 | 217.88 | 235.56 | 236.49 | 270.38 | 263.73 | 255.38 | 249.31 | 295.93 | 298.47 | ||||||||||
EBITDA | 125.39 | 126.69 | 118.32 | 105.66 | 158.35 | 147.63 | 129.25 | 123.64 | 157.06 | 157.49 | ||||||||||
| Depreciation/Amortization | 26.80 | 27.66 | 32.30 | 34.14 | 34.90 | 35.23 | 34.16 | 34.19 | 35.84 | 39.60 | ||||||||||
| PBIT | 98.59 | 99.03 | 86.02 | 71.52 | 123.45 | 112.40 | 95.09 | 89.45 | 121.22 | 117.89 | ||||||||||
| Interest & Other Items | 13.34 | 14.26 | 16.85 | 18.16 | 18.10 | 18.07 | 18.12 | 18.08 | 18.85 | 20.20 | ||||||||||
| PBT | 85.25 | 84.77 | 69.17 | 53.36 | 105.35 | 94.33 | 76.97 | 71.37 | 102.37 | 97.69 | ||||||||||
| Taxes & Other Items | 22.34 | 22.64 | 18.20 | 13.82 | 26.48 | 25.64 | 20.64 | 17.88 | 27.11 | 25.17 | ||||||||||
| Net Income | 62.91 | 62.13 | 50.97 | 39.54 | 78.87 | 68.69 | 56.33 | 53.49 | 75.26 | 72.52 | ||||||||||
| EPS | 6.20 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 |
RAINBOW Company Updates
FY 2026FY 2026
Investor Presentation
Jan 28PDF
Nov 13PDF
Jul 26PDF
RAINBOW Stock Peers
RAINBOW Past Performance & Peer Comparison
RAINBOW Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Rainbow Children's Medicare Ltd | 47.02 | 7.76 | 0.27% |
| Apollo Hospitals Enterprise Ltd | 74.58 | 9.72 | 0.17% |
| Max Healthcare Institute Ltd | 88.32 | 10.13 | 0.15% |
| Fortis Healthcare Ltd | 79.98 | 6.75 | 0.12% |
RAINBOW Stock Price Comparison
Compare RAINBOW with any stock or ETFCompare RAINBOW with any stock or ETF
RAINBOW
RAINBOW Holdings
RAINBOW Shareholdings
RAINBOW Promoter Holdings Trend
RAINBOW Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
RAINBOW Institutional Holdings Trend
RAINBOW Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 2.62%
RAINBOW Shareholding Pattern
RAINBOW Shareholding Pattern
RAINBOW Shareholding History
RAINBOW Shareholding History
Foreign Institutions
Mutual Funds Invested in RAINBOW
Mutual Funds Invested in RAINBOW
No mutual funds holding trends are available
Top 5 Mutual Funds holding Rainbow Children's Medicare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3408% | Percentage of the fund’s portfolio invested in the stock 0.94% | Change in the portfolio weight of the stock over the last 3 months 0.26% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 69/117 (+6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.5974% | Percentage of the fund’s portfolio invested in the stock 1.08% | Change in the portfolio weight of the stock over the last 3 months -0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/86 (-8) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2132% | Percentage of the fund’s portfolio invested in the stock 0.17% | Change in the portfolio weight of the stock over the last 3 months 0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 278/300 (-9) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing RAINBOW stock
smallcases containing RAINBOW stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Rainbow Children's Medicare Ltd
RAINBOW Events
RAINBOW Events
RAINBOW Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
RAINBOW Dividend Trend
No dividend trend available
RAINBOW Upcoming Dividends
RAINBOW Upcoming Dividends
No upcoming dividends are available
RAINBOW Past Dividends
RAINBOW Past Dividends
Cash Dividend
Ex DateEx DateJun 27, 2025
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jun 27, 2025
Cash Dividend
Ex DateEx DateJul 23, 2024
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jul 23, 2024
Cash Dividend
Ex DateEx DateJun 22, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jun 22, 2023
Cash Dividend
Ex DateEx DateSep 7, 2022
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 7, 2022
RAINBOW Stock News & Opinions
RAINBOW Stock News & Opinions
Articles & Videos
Corporate
Rainbow Childrens Medicare to declare Quarterly Results
Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit declines 4.59% in the September 2025 quarter
Net profit of Rainbow Children's Medicare declined 4.59% to Rs 75.25 crore in the quarter ended September 2025 as against Rs 78.87 crore during the previous quarter ended September 2024. Sales rose 6.55% to Rs 444.80 crore in the quarter ended September 2025 as against Rs 417.46 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales444.80417.46 7 OPM %33.4735.23 - PBDT138.21140.25 -1 PBT102.37105.35 -3 NP75.2578.87 -5 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to hold board meeting
Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit rises 35.34% in the June 2025 quarter
Net profit of Rainbow Children's Medicare rose 35.34% to Rs 53.50 crore in the quarter ended June 2025 as against Rs 39.53 crore during the previous quarter ended June 2024. Sales rose 6.88% to Rs 352.93 crore in the quarter ended June 2025 as against Rs 330.22 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales352.93330.22 7 OPM %29.3628.38 - PBDT105.5687.50 21 PBT71.3753.35 34 NP53.5039.53 35 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to discuss results
Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 26 July 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to hold AGM
Rainbow Childrens Medicare announced that the 27th Annual General Meeting(AGM) of the company will be held on 5 July 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit rises 10.54% in the March 2025 quarter
Net profit of Rainbow Children's Medicare rose 10.54% to Rs 56.34 crore in the quarter ended March 2025 as against Rs 50.97 crore during the previous quarter ended March 2024. Sales rose 8.50% to Rs 370.11 crore in the quarter ended March 2025 as against Rs 341.10 crore during the previous quarter ended March 2024. For the full year,net profit rose 12.18% to Rs 243.42 crore in the year ended March 2025 as against Rs 217.00 crore during the previous year ended March 2024. Sales rose 16.88% to Rs 1515.87 crore in the year ended March 2025 as against Rs 1296.90 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales370.11341.10 9 1515.871296.90 17 OPM %31.0030.94 -32.3233.07 - PBDT111.13101.47 10 468.44406.90 15 PBT76.9769.17 11 330.00294.81 12 NP56.3450.97 11 243.42217.00 12 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Board of Rainbow Childrens Medicare recommends final dividend
Rainbow Childrens Medicare announced that the Board of Directors of the Company at its meeting held on 24 May 2025, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to declare Quarterly Results
Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Spotlight
Volumes spurt at Rainbow Childrens Medicare Ltd counter
Castrol India Ltd, Triveni Engineering and Industries Ltd, Laurus Labs Ltd, Aurobindo Pharma Ltd are among the other stocks to see a surge in volumes on NSE today, 04 April 2025.Rainbow Childrens Medicare Ltd registered volume of 15.86 lakh shares by 14:14 IST on NSE, a 5.97 fold spurt over two-week average daily volume of 2.66 lakh shares. The stock rose 2.67% to Rs.1,410.40. Volumes stood at 51271 shares in the last session.Castrol India Ltd notched up volume of 196.67 lakh shares by 14:14 IST on NSE, a 4.49 fold spurt over two-week average daily volume of 43.78 lakh shares. The stock rose 0.60% to Rs.202.15. Volumes stood at 52.53 lakh shares in the last session.Triveni Engineering and Industries Ltd notched up volume of 12.53 lakh shares by 14:14 IST on NSE, a 3.98 fold spurt over two-week average daily volume of 3.15 lakh shares. The stock slipped 0.59% to Rs.378.70. Volumes stood at 3.58 lakh shares in the last session.Laurus Labs Ltd notched up volume of 63.36 lakh shares by 14:14 IST on NSE, a 3.87 fold spurt over two-week average daily volume of 16.39 lakh shares. The stock slipped 7.38% to Rs.574.85. Volumes stood at 37.44 lakh shares in the last session.Aurobindo Pharma Ltd notched up volume of 64.83 lakh shares by 14:14 IST on NSE, a 3.77 fold spurt over two-week average daily volume of 17.21 lakh shares. The stock slipped 6.08% to Rs.1,104.85. Volumes stood at 75.02 lakh shares in the last session.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.51%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 1.75% to 1.9%
Over the last 5 years, net income has grown at a yearly rate of 34.29%, vs industry avg of 42.46%